Literature DB >> 15024624

Persistent colonization of nine cystic fibrosis patients with an Achromobacter (Alcaligenes) xylosoxidans clone.

M Kanellopoulou1, S Pournaras, H Iglezos, N Skarmoutsou, E Papafrangas, A N Maniatis.   

Abstract

The present study was conducted to investigate the increasing incidence of Achromobacter (previously Alcaligenes) xylosoxidans isolates being recovered from sputum samples of cystic fibrosis patients at a cystic fibrosis department for adults in Athens, Greece. During the 1-year study period, a total of 34 isolates were detected persistently in 9 of 71 cystic fibrosis patients. The isolates exhibited resistance to multiple antimicrobial agents. Isolates that were recovered repeatedly from each patient exhibited identical macrorestriction profiles with pulsed-field gel electrophoresis, indicating that the same strain persisted in the lungs of these patients. Isolates from five of the patients were genetically related, suggesting a common-source outbreak of Achromobacter xylosoxidans colonization or infection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15024624     DOI: 10.1007/s10096-004-1105-9

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  14 in total

1.  Outbreak of infections caused by Pseudomonas aeruginosa producing VIM-1 carbapenemase in Greece.

Authors:  A Tsakris; S Pournaras; N Woodford; M F Palepou; G S Babini; J Douboyas; D M Livermore
Journal:  J Clin Microbiol       Date:  2000-03       Impact factor: 5.948

2.  Detection of a variant metallo-beta-lactamase, IMP-10, from two unrelated strains of Pseudomonas aeruginosa and an alcaligenes xylosoxidans strain.

Authors:  Shizuko Iyobe; Haruko Kusadokoro; Ayako Takahashi; Sachie Yomoda; Toyoji Okubo; Akio Nakamura; Koji O'Hara
Journal:  Antimicrob Agents Chemother       Date:  2002-06       Impact factor: 5.191

3.  Comparison of polymerase chain reaction and pulsed-field gel electrophoresis for the epidemiological typing of Alcaligenes xylosoxidans subsp. xylosoxidans in a burn unit.

Authors:  Y H Lin; P Y Liu; Z Y Shi; Y J Lau; B S Hu
Journal:  Diagn Microbiol Infect Dis       Date:  1997-08       Impact factor: 2.803

4.  Persistent airway colonization with Alcaligenes xylosoxidans in two brothers with cystic fibrosis.

Authors:  H Peltroche-Llacshuanga; H Peltroche-Llacsahuanga; H Kentrup; G Haase
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-02       Impact factor: 3.267

Review 5.  Achromobacter xylosoxidans bacteremia: report of four cases and review of the literature.

Authors:  J M Duggan; S J Goldstein; C E Chenoweth; C A Kauffman; S F Bradley
Journal:  Clin Infect Dis       Date:  1996-09       Impact factor: 9.079

6.  Identification and antimicrobial susceptibility of Alcaligenes xylosoxidans isolated from patients with cystic fibrosis.

Authors:  L Saiman; Y Chen; S Tabibi; P San Gabriel; J Zhou; Z Liu; L Lai; S Whittier
Journal:  J Clin Microbiol       Date:  2001-11       Impact factor: 5.948

7.  Use of random amplified polymorphic DNA PCR to examine epidemiology of Stenotrophomonas maltophilia and Achromobacter (Alcaligenes) xylosoxidans from patients with cystic fibrosis.

Authors:  J W Krzewinski; C D Nguyen; J M Foster; J L Burns
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

Review 8.  Bacteremia and respiratory involvement by Alcaligenes xylosoxidans in patients infected with the human immunodeficiency virus.

Authors:  R Manfredi; A Nanetti; M Ferri; F Chiodo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-12       Impact factor: 3.267

9.  Emendation of genus Achromobacter and Achromobacter xylosoxidans (Yabuuchi and Yano) and proposal of Achromobacter ruhlandii (Packer and Vishniac) comb. nov., Achromobacter piechaudii (Kiredjian et al.) comb. nov., and Achromobacter xylosoxidans subsp. denitrificans (Rüger and Tan) comb. nov.

Authors:  E Yabuuchi; Y Kawamura; Y Kosako; T Ezaki
Journal:  Microbiol Immunol       Date:  1998       Impact factor: 1.955

10.  Alcaligenes infection in cystic fibrosis.

Authors:  Kenneth Tan; Steven P Conway; Keith G Brownlee; Christine Etherington; Daniel G Peckham
Journal:  Pediatr Pulmonol       Date:  2002-08
View more
  20 in total

1.  VIM-2 metallo-beta-lactamase in Achromobacter xylosoxidans in Europe.

Authors:  D Sofianou; A Markogiannakis; E Metzidie; S Pournaras; A Tsakris
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-12       Impact factor: 3.267

2.  Achromobacter xylosoxidans: characterization of strains in Brazilian cystic fibrosis patients.

Authors:  Rosana H V Pereira; Ana Paula Carvalho-Assef; Rodolpho M Albano; Tania W Folescu; Marcia C M F Jones; Robson S Leão; Elizabeth A Marques
Journal:  J Clin Microbiol       Date:  2011-08-17       Impact factor: 5.948

Review 3.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

4.  Prevalence and Outcomes of Achromobacter Species Infections in Adults with Cystic Fibrosis: a North American Cohort Study.

Authors:  B D Edwards; J Greysson-Wong; R Somayaji; B Waddell; F J Whelan; D G Storey; H R Rabin; M G Surette; M D Parkins
Journal:  J Clin Microbiol       Date:  2017-04-26       Impact factor: 5.948

5.  Shared genotypes of Achromobacter xylosoxidans strains isolated from patients at a cystic fibrosis rehabilitation center.

Authors:  Sabine Van Daele; Rita Verhelst; Geert Claeys; Gerda Verschraegen; Hilde Franckx; Leen Van Simaey; Catharine de Ganck; Frans De Baets; Mario Vaneechoutte
Journal:  J Clin Microbiol       Date:  2005-06       Impact factor: 5.948

Review 6.  The changing microbial epidemiology in cystic fibrosis.

Authors:  John J Lipuma
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

7.  Outbreak of long-term intravascular catheter-related bacteremia due to Achromobacter xylosoxidans subspecies xylosoxidans in a hemodialysis unit.

Authors:  D Tena; R Carranza; J R Barberá; S Valdezate; J M Garrancho; M Arranz; J A Sáez-Nieto
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2005-11       Impact factor: 3.267

8.  Molecular characterization of Achromobacter isolates from cystic fibrosis and non-cystic fibrosis patients in Madrid, Spain.

Authors:  Laura Barrado; Patricia Brañas; M Ángeles Orellana; M Teresa Martínez; Gloria García; Joaquín R Otero; Fernando Chaves
Journal:  J Clin Microbiol       Date:  2013-03-27       Impact factor: 5.948

9.  Got black swimming dots in your cell culture? Identification of Achromobacter as a novel cell culture contaminant.

Authors:  Jennifer Sue Gray; Janette Marie Birmingham; Jenifer Imig Fenton
Journal:  Biologicals       Date:  2009-11-18       Impact factor: 1.856

10.  Low rates of Pseudomonas aeruginosa misidentification in isolates from cystic fibrosis patients.

Authors:  Timothy J Kidd; Kay A Ramsay; Honghua Hu; Peter T P Bye; Mark R Elkins; Keith Grimwood; Colin Harbour; Guy B Marks; Michael D Nissen; Philip J Robinson; Barbara R Rose; Theo P Sloots; Claire E Wainwright; Scott C Bell
Journal:  J Clin Microbiol       Date:  2009-03-04       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.